SCHEMBL3769710

SCHEMBL3769710

C=C[Si](C)(C)CCN(c1ccccc1)[Si](C)(C)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MTNR1A P48039 1/20 0.30
MTNR1B P49286 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3768094 0.91 MEN1 (0.30) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL3774854 0.84 MEN1 (0.30) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL3772489 0.84 MTNR1A (0.33) MTNR1AMTNR1B
SCHEMBL3765419 0.80 MTNR1A (0.34) MTNR1AMTNR1B
SCHEMBL3770911 0.79 MTNR1A (0.30) MTNR1AMTNR1B
SCHEMBL3765393 0.79 MTNR1A (0.43) MTNR1AMTNR1B
SCHEMBL15360546 0.78 MEN1 (0.33) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL15361251 0.78 MAPT (0.35) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL15361119 0.77 MEN1 (0.33) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL3772474 0.75 MTNR1A (0.32) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436166-B2 Amino-containing vinylsilane compounds and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-07 US disclosed
US-20100317852-A1 AMINO-CONTAINING VINYLSILANE COMPOUNDS AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317852-A1 AMINO-CONTAINING VINYLSILANE COMPOUNDS AND MAKING METHOD BHMT2, GNMT, VASP MEN1 1223/4885CYP3A4 2558/4885CYP2C9 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.